Rafferty Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-351,337
| Closed | -$358K | – | 1138 |
|
|
2024
Q4 | $358K | Buy |
+351,337
| New | +$358K | ﹤0.01% | 990 |
|
|
2023
Q2 | – | Sell |
-660,015
| Closed | -$1.16M | – | 1140 |
|
|
2023
Q1 | $1.16M | Sell |
660,015
-83,888
| -11% | -$148K | 0.01% | 768 |
|
|
2022
Q4 | $2.34M | Buy |
743,903
+304,949
| +69% | +$958K | 0.02% | 533 |
|
|
2022
Q3 | $2.15M | Buy |
438,954
+128,898
| +42% | +$632K | 0.02% | 492 |
|
|
2022
Q2 | $1.28M | Sell |
310,056
-181,645
| -37% | -$752K | 0.01% | 575 |
|
|
2022
Q1 | $2.86M | Buy |
491,701
+115,124
| +31% | +$669K | 0.02% | 518 |
|
|
2021
Q4 | $2.82M | Buy |
376,577
+177,395
| +89% | +$1.33M | 0.01% | 551 |
|
|
2021
Q3 | $1.8M | Sell |
199,182
-9,881
| -5% | -$89K | 0.01% | 671 |
|
|
2021
Q2 | $2.5M | Sell |
209,063
-79,667
| -28% | -$953K | 0.02% | 599 |
|
|
2021
Q1 | $3.62M | Buy |
288,730
+228,869
| +382% | +$2.87M | 0.02% | 378 |
|
|
2020
Q4 | $934K | Sell |
59,861
-128,740
| -68% | -$2.01M | 0.01% | 521 |
|
|
2020
Q3 | $1.78M | Buy |
188,601
+116,812
| +163% | +$1.1M | 0.02% | 451 |
|
|
2020
Q2 | $643K | Buy |
71,789
+56,456
| +368% | +$506K | 0.01% | 650 |
|
|
2020
Q1 | $98K | Sell |
15,333
-114,921
| -88% | -$735K | ﹤0.01% | 559 |
|
|
2019
Q4 | $1.09M | Sell |
130,254
-140,109
| -52% | -$1.17M | 0.02% | 535 |
|
|
2019
Q3 | $2.45M | Buy |
270,363
+7,986
| +3% | +$72.3K | 0.04% | 288 |
|
|
2019
Q2 | $2.83M | Sell |
262,377
-23,135
| -8% | -$249K | 0.05% | 265 |
|
|
2019
Q1 | $2.72M | Buy |
+285,512
| New | +$2.72M | 0.04% | 256 |
|